These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 25844569)

  • 21. Illness perception and knowledge with regard to prediabetes and type 2 diabetes: a pilot study of emergency department patients and staff.
    Weiland TJ; Nguyen M; Jelinek GA
    Eur J Emerg Med; 2012 Dec; 19(6):353-8. PubMed ID: 22095155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health beliefs toward cardiovascular risk reduction in patients admitted to chest pain observation units.
    Katz DA; Graber M; Birrer E; Lounsbury P; Baldwin A; Hillis SL; Christensen AJ
    Acad Emerg Med; 2009 May; 16(5):379-87. PubMed ID: 19302365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conference on "Multidisciplinary approaches to nutritional problems". Symposium on "Diabetes and health". Nutrition interventions for the prevention of type 2 diabetes.
    Steyn NP; Lambert EV; Tabana H
    Proc Nutr Soc; 2009 Feb; 68(1):55-70. PubMed ID: 19068148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing type 2 diabetes: genes or lifestyle?
    Weber MB; Narayan KM
    Prim Care Diabetes; 2008 Jun; 2(2):65-6. PubMed ID: 18684424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hispanic adults' beliefs about type 2 diabetes: clinical implications.
    Hatcher E; Whittemore R
    J Am Acad Nurse Pract; 2007 Oct; 19(10):536-45. PubMed ID: 17897118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey.
    Graham ID; Logan DM; Hughes-Benzie R; Evans WK; Perras H; McAuley LM; Laupacis A; Stern H
    Cancer Prev Control; 1998 Aug; 2(4):167-72. PubMed ID: 10093629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What follow-up care and self-management support do patients with type 2 diabetes want after their first acute coronary event? A qualitative study.
    Kasteleyn MJ; Gorter KJ; van Puffelen AL; Heijmans M; Vos RC; Jansen H; Rutten GE
    Prim Care Diabetes; 2014 Oct; 8(3):195-206. PubMed ID: 24389352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of the factors associated with interest in predictive genetic testing for obesity, type II diabetes and heart disease.
    Collins J; Ryan L; Truby H
    J Hum Nutr Diet; 2014 Oct; 27(5):479-88. PubMed ID: 24236642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Information-seeking and sharing behavior following genomic testing for diabetes risk.
    Mills R; Powell J; Barry W; Haga SB
    J Genet Couns; 2015 Feb; 24(1):58-66. PubMed ID: 24927802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical application of genetic testing in type 2 diabetes: a patient and physician survey.
    Grant RW; Hivert M; Pandiscio JC; Florez JC; Nathan DM; Meigs JB
    Diabetologia; 2009 Nov; 52(11):2299-2305. PubMed ID: 19727660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic counseling as a tool for type 2 diabetes prevention: a genetic counseling framework for common polygenetic disorders.
    Waxler JL; O'Brien KE; Delahanty LM; Meigs JB; Florez JC; Park ER; Pober BR; Grant RW
    J Genet Couns; 2012 Oct; 21(5):684-91. PubMed ID: 22302620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Type 2: Linguistic Agency Assignment in Diabetes Prevention Policy Messaging.
    Glowacki EM; McGlone MS; Bell RA
    J Health Commun; 2016; 21(4):457-68. PubMed ID: 26959860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes familial risk personalization process profiles: Implications for patient-provider communication.
    Daack-Hirsch S; Schumacher AC; Shah L; Campo S
    Res Nurs Health; 2019 Oct; 42(5):369-381. PubMed ID: 31368184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes.
    Markowitz SM; Park ER; Delahanty LM; O'Brien KE; Grant RW
    Diabetes Care; 2011 Mar; 34(3):568-73. PubMed ID: 21285385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic susceptibility testing for chronic disease and intention for behavior change in healthy young adults.
    Vassy JL; Donelan K; Hivert MF; Green RC; Grant RW
    J Community Genet; 2013 Apr; 4(2):263-71. PubMed ID: 23435806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public interest and expectations concerning commercial genotyping and genetic risk assessment.
    Makeeva OA; Markova VV; Puzyrev VP
    Per Med; 2009 May; 6(3):329-341. PubMed ID: 29783514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can genetic information change patient behavior to reduce Type 2 diabetes risk?
    Vassy JL
    Per Med; 2013 Jan; 10(1):. PubMed ID: 24358047
    [No Abstract]   [Full Text] [Related]  

  • 38. Perceived impact of Nepalese food and food culture in diabetes.
    Sapkota S; Brien JE; Gwynn J; Flood V; Aslani P
    Appetite; 2017 Jun; 113():376-386. PubMed ID: 28288801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes Causation Beliefs Among Spanish-Speaking Patients.
    Concha JB; Mayer SD; Mezuk BR; Avula D
    Diabetes Educ; 2016 Feb; 42(1):116-25. PubMed ID: 26568376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on genetic and genomic technologies in an academic medical center: the duke experience.
    Katsanis SH; Minear MA; Vorderstrasse A; Yang N; Reeves JW; Rakhra-Burris T; Cook-Deegan R; Ginsburg GS; Simmons LA
    J Pers Med; 2015 Apr; 5(2):67-82. PubMed ID: 25854543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.